Connecticut sues Eli Lilly over Zyprexa marketing

NEW YORK, March 11 (Reuters) - The state of Connecticut has sued Eli Lilly and Co (LLY.N: Quote, Profile, Research), accusing the drugmaker of illegally marketing and concealing serious side effects of its top-selling schizophrenia medicine Zyprexa, Attorney General Richard Blumenthal announced on Tuesday.

Blumenthal is seeking to recover "millions of taxpayer and consumer dollars improperly spent on Zyprexa as a result of its illegal marketing, and millions more spent for treatment of serious side effects from Zyprexa," according to a press statement from the attorney general's office. (Reporting by Bill Berkrot)